Hong Huang Selected Research

Hong Huang Research Topics

Disease

29	Neoplasms (Cancer) 01/2022 - 04/2002
21	Inflammation (Inflammations) 03/2022 - 05/2007
9	Hypoxia (Hypoxemia) 05/2022 - 01/2003
9	Wounds and Injuries (Trauma) 04/2020 - 02/2012
8	Insulin Resistance 06/2022 - 08/2011
8	Lung Neoplasms (Lung Cancer) 01/2022 - 09/2003
6	Rheumatoid Arthritis 11/2022 - 10/2020
6	Cognitive Dysfunction 03/2022 - 03/2016
6	Fibrosis (Cirrhosis) 01/2021 - 11/2003
6	Aggressive Periodontitis (Periodontosis) 11/2020 - 01/2013
5	Neuroinflammatory Diseases 01/2022 - 01/2020
5	Infections 01/2022 - 05/2006
5	Type 2 Diabetes Mellitus (MODY) 11/2021 - 04/2010
5	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 04/2010
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2016 - 08/2009
4	Carcinogenesis 01/2022 - 04/2002
4	Adenocarcinoma of Lung 01/2022 - 01/2003
4	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 02/2007
4	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 10/2014
4	Hyperglycemia 01/2019 - 08/2009
4	Lung Injury 01/2017 - 10/2003
4	Hypercapnia 11/2006 - 05/2004
3	Body Weight (Weight, Body) 06/2022 - 01/2016
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 01/2020
3	Sepsis (Septicemia) 01/2021 - 05/2006
3	Necrosis 10/2020 - 03/2003
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2020 - 03/2005
3	Birth Weight (Birth Weights) 10/2018 - 05/2014
2	Obesity 06/2022 - 01/2021
2	Overweight 06/2022 - 01/2016
2	Mental Disorders (Mental Disorder) 05/2022 - 10/2021
2	Osteoporosis 05/2022 - 12/2003
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2022 - 10/2021
2	Arthritis (Polyarthritis) 01/2022 - 02/2007
2	Pneumonia (Pneumonitis) 01/2022 - 08/2006
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 09/2017
2	Acquired Hyperostosis Syndrome (SAPHO Syndrome) 01/2022 - 03/2021
2	Pain (Aches) 11/2021 - 01/2014
2	Obstructive Sleep Apnea 01/2021 - 08/2012
2	Pathologic Constriction (Stenosis) 01/2021 - 12/2020
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 07/2003
2	Atherosclerosis 01/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2002
15	Biomarkers (Surrogate Marker)IBA 11/2022 - 04/2002
8	Messenger RNA (mRNA)IBA 07/2019 - 05/2004
7	CytokinesIBA 11/2020 - 06/2005
7	Glucose (Dextrose)FDA LinkGeneric 10/2018 - 08/2011
7	CollagenIBA 05/2017 - 11/2003
6	C-Reactive ProteinIBA 04/2022 - 09/2012
6	Pharmaceutical PreparationsIBA 01/2022 - 12/2009
6	Biological ProductsIBA 01/2021 - 11/2003
5	Insulin (Novolin)FDA Link 06/2022 - 01/2012
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2003
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 06/2005
5	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 01/2017
4	Sirtuin 1IBA 01/2022 - 10/2019
4	Indicators and Reagents (Reagents)IBA 01/2022 - 11/2003
4	LipopolysaccharidesIBA 01/2020 - 06/2005
4	EnzymesIBA 01/2015 - 05/2008
3	Toll-Like Receptor 4IBA 03/2022 - 06/2005
3	Interleukin-6 (Interleukin 6)IBA 03/2022 - 01/2016
3	Liposomes (Liposome)IBA 01/2022 - 05/2004
3	Superoxide DismutaseIBA 01/2022 - 11/2003
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021 - 01/2020
3	Tobacco Smoke Pollution (Passive Smoking)IBA 09/2019 - 01/2015
3	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 06/2008
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2017 - 01/2016
3	Streptozocin (Streptozotocin)FDA Link 03/2017 - 08/2009
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2016 - 02/2012
3	Therapeutic UsesIBA 01/2016 - 12/2003
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2015 - 06/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2015 - 08/2009
3	trichostatin A (A 300)IBA 01/2015 - 09/2003
3	theasinensin AIBA 01/2015 - 01/2003
3	Pattern Recognition ReceptorsIBA 05/2006 - 06/2005
2	GlucocorticoidsIBA 04/2022 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2022 - 12/2013
2	NF-kappa B (NF-kB)IBA 03/2022 - 01/2020
2	AntibodiesIBA 03/2022 - 04/2020
2	Malondialdehyde (Propanedial)IBA 01/2022 - 10/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2002
2	Hematoxylin (Haematoxylon)IBA 01/2022 - 01/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 01/2017
2	tofacitinibIBA 01/2022 - 10/2020
2	oxidized low density lipoproteinIBA 01/2021 - 01/2017
2	SolutionsIBA 01/2021 - 01/2016
2	Apolipoproteins E (ApoE)IBA 01/2021 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2021 - 11/2020
2	Lipoproteins (Lipoprotein)IBA 01/2021 - 06/2005
2	Scopolamine (Hyoscine)FDA Link 01/2021 - 01/2021
2	Sucrose (Saccharose)IBA 01/2021 - 01/2019
2	Neuroprotective AgentsIBA 01/2021 - 06/2016
2	LipidsIBA 01/2021 - 10/2017
2	Immune Checkpoint InhibitorsIBA 01/2021 - 12/2020
2	EndotoxinsIBA 01/2021 - 10/2003
2	Prednisone (Sone)FDA LinkGeneric 01/2021 - 12/2003
2	Antirheumatic Agents (DMARD)IBA 01/2021 - 10/2020

Therapy/Procedure

28	Therapeutics 04/2022 - 09/2003
4	Ligation 01/2021 - 12/2011
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 01/2021